What is the quality of evidence regarding the relative effect of MDTc versus cardiology for high risk HF outcomes?
The quality of evidence regarding the relative effect of MDTc versus cardiology for high risk HF outcomes is MODERATE due to imprecision, LOW for quality of life due to risk of bias and imprecision, and LOW for prescribed ACE-I and beta-blocker due to risk of bias and imprecision. (a) Downgraded by 1 increment if the confidence interval crossed one MID or by 2 increments if the confidence interval crossed both MIDs. (b) Downgraded by 1 increment if the majority of the evidence was at high risk of bias, and downgraded by 2 increments if the majority of the evidence was at very high risk of bias. 